Supplementary information reveals biodistribution and serum stability data for drug conjugates, suggesting enhanced therapeutic potential.
Detailed synthetic procedures and characterization of the presented compounds are described in the Supplementary Information , together with additional serum stability data, biodistribution data, and statistical analysis of therapy experiments.
No takes yet. Share an insight, caveat, or question.
Georgiev et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: